Nasdaq:US$13.41 (-0.23) | HKEX:HK$21.15 (+0.00) | AIM:£2.22 (+0.02)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 27 Sep 2015

ESMO 2015: Phase II trial of fruquintinib in metastatic colorectal cancer

1 items
View PDF